Consolidative Radiotherapy After Gemcitabine-Platinum Chemotherapy in De Novo Metastatic Nasopharyngeal Carcinoma: Impact of Chemotherapy Backbone and Prognostic Factors on Survival.
INTRODUCTION De novo metastatic nasopharyngeal carcinoma (NPC) has a poor prognosis despite modern chemotherapy. Gemcitabine-cisplatin is the standard chemotherapy backbone, whereas carboplatin is commonly used as a cisplatin alternative for its better tolerability. This study evaluated high-dose locoregional radiother...